الفهرس 
Material and methodsOnly 14 pages are availabe for public view
 |  | from | 144 |  |  |
| | | from | 144 | | |
Abstract
Several pathophysiological mechanisms have been proposed for
the development of polycystic ovary syndrome.
Numerous reports confirm the role of vascular endothelial growth
factor as an important mediator of the syndrome.
It induces strong angiogenic response, accompanied by extensive
cyst formation in the ovary.
The primary cause of polycystic ovary syndrome is still unknown
so treatment is directed at the symptoms of the disorder.
Few treatment approaches improve all aspects of the syndrome but
the patient’s desire for fertility must be respected.
Despite of the high success rate of clomiphene citrate in most
anovulatory women, treatment has low success rates in inducing
ovulation in women with polycystic ovary syndrome.
We are looking forward to test other angiogenic factors which
might be helpful as predictors for the effect of NAC as an adjuvant to CC